Navigation Links
Quark Pharmaceuticals Appoints New Chief Medical Officer
Date:9/4/2007

FREMONT, Calif., Sept. 4 /PRNewswire/ -- Quark Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on discovering and developing novel RNA interference-based therapeutics, announced today that J. Joseph Marr, M.D. has been appointed as the Company's new Chief Medical Officer.

In this capacity, Dr. Marr will play a key role in supporting Quark's current clinical programs and in outlining the goals and plans of the Company's pipeline.

Prior to joining Quark, Dr. Marr served as President of BioMed, LLC, a medical and biotechnology consulting company, since 1999. He simultaneously served as General Partner of Pacific Rim Ventures, a venture capital firm, since 2000. Previously, Dr. Marr held positions at Immulogic Pharmaceutical Corporation from 1996 to 1999, serving most recently as President, CEO, and member of the Board of Directors. Dr. Marr previously served as Vice President, Research and Development of Ribozyme Pharmaceuticals, Inc. and as Senior Vice President, Discovery Research at Monsanto Searle Research and Development. Dr. Marr received a Doctorate of Medicine from The Johns Hopkins University School of Medicine and has held professorial positions at University of Colorado Health Sciences Center, St. Louis University School of Medicine, and Washington University School of Medicine.

Daniel Zurr, CEO of Quark Pharmaceuticals, commented, "Dr. Marr brings to Quark nearly 20 years experience in clinical research positions at note worthy pharmaceutical companies, including Immulogic and Ribozyme. His extensive experience as a consultant to global pharmaceutical companies, combined with his past work as a practicing physician, adds to the depth of our team as we aggressively expand our clinical trials program. With his addition, we are well prepared to meet the increasing workload of our extensive clinical pipeline."

Currently Quark is conducting a Phase I/IIa clinical trial for its lead product candidate, RTP80
'/>"/>

SOURCE Quark Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
2. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
3. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
4. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
5. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
6. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
7. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
8. Pro-Pharmaceuticals Updates Progress of Clinical Trials & Davanat 505 (b)(2) Filings
9. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
10. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
11. Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple Myeloma and Waldenstroms Macroglobulinemia

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/8/2009)...ARP Praises House Passage of Health Care Reform Bi...edicare, improve coverage for all Americans ,,... Today the United States House of Representatives ...t would strengthen Medicare for seniors and end di...llions of Americans out of affordable health cover...
(Date:11/7/2009)...AMI BEACH, Fla., Nov. 7 Patients r... is an effective therapy in treating acute swellin... serious genetic disorder, according to data prese..., Asthma & Immunology (ACAAI) Annual Meeting. ...tients conducted in parallel with the ongoing, pro...
(Date:11/7/2009)...AMI BEACH, Fla., Nov. 7 Most patie...l symptoms that signal an oncoming HAE attack givi...ent and decrease the morbidity associated with tha...oday at the 2009 American College of Allergy, Asth...recognition of symptoms such as fatigue and nausea...
Breaking Medicine Technology:AARP Idaho Key Vote News Alert 2AARP Idaho Key Vote News Alert 3Hereditary Angioedema Patients Report: C1-Esterase Inhibitor Concentrate Effective in Treating Acute Attacks, Helps Them Avoid Emergency Care 2Hereditary Angioedema Patients Report: C1-Esterase Inhibitor Concentrate Effective in Treating Acute Attacks, Helps Them Avoid Emergency Care 3Prodromal Symptoms Warn of Hereditary Angioedema Attacks, Give Patients Time to Start Therapy and Decrease Morbidity 2Prodromal Symptoms Warn of Hereditary Angioedema Attacks, Give Patients Time to Start Therapy and Decrease Morbidity 3A Solution for Successful Wound Management 3A B Braun Announces Prontosan 28R 29 Availability at Symposium for Advanced Wound Care 28SAWC 29 Fall Ev 57045 1A Solution for Successful Wound Management 3A B Braun Announces Prontosan 28R 29 Availability at Symposium for Advanced Wound Care 28SAWC 29 Fall Ev 57045 2A Solution for Successful Wound Management 3A B Braun Announces Prontosan 28R 29 Availability at Symposium for Advanced Wound Care 28SAWC 29 Fall Ev 57045 3Personal Protective Equipment Conference Set for November 17 19 in Fort Lauderdale 57043 1Personal Protective Equipment Conference Set for November 17 19 in Fort Lauderdale 57043 2DNA2 0 Unlocks The Secrets Of Optimized Gene Design 3A Company Identifies Codon Choice Design Principles for Optimal Protein Expression 14020 1DNA2 0 Unlocks The Secrets Of Optimized Gene Design 3A Company Identifies Codon Choice Design Principles for Optimal Protein Expression 14020 2DNA2 0 Unlocks The Secrets Of Optimized Gene Design 3A Company Identifies Codon Choice Design Principles for Optimal Protein Expression 14020 3DNA2 0 Unlocks The Secrets Of Optimized Gene Design 3A Company Identifies Codon Choice Design Principles for Optimal Protein Expression 14020 4
... Cadence Pharmaceuticals,Inc. (Nasdaq: CADX ), a ...developing and commercializing proprietary product...tting, today announced that it will release its,se...pens on Thursday,August 7, 2008., Cadence managem...o,discuss the financial results and provide a clin...
...nalyses Have Conflicting Results -, CHICAGO, July...nking processes among placebo groups in Alzheimer,... to show the effectiveness,of new Alzheimer therap...he,2008 Alzheimer,s Association International Conf...go., Alzheimer clinical trials seek to show that ...
Other Medicine Technology:Cadence Pharmaceuticals to Host Conference Call and Webcast to Discuss Second Quarter 2008 Financial Results and Provide a Clinical Program Update on August 7, 2008 2Controversy About Lack of Placebo Group Decline in Alzheimer's Clinical Trials 2Controversy About Lack of Placebo Group Decline in Alzheimer's Clinical Trials 3Controversy About Lack of Placebo Group Decline in Alzheimer's Clinical Trials 4Controversy About Lack of Placebo Group Decline in Alzheimer's Clinical Trials 5
(Date:11/9/2009)... On Tuesday November 10th, at 5:30 pm CST, ... lecture on Radiation Therapy Options for Mesothel...teleconference, and via the mesocare.org website. ...November 9, 2009 -- Mesothelioma lecture on Tues... is sponsoring a lecture by Veronica Garza of MD A...
(Date:11/9/2009)... Doctor house calls now available in New Yo... New York, NY (PRWEB) November 9, 20..., will now offer routine house calls to residents ...le to request a house call by calling the office...egman.com . The convenience of being able to see t...
(Date:11/9/2009)... Lumension,s advanced device control capabi...ce insider risk and quickly enhance their data sec... Scottsdale, AZ (PRWEB) Nov. 9, 2009 -- Lumensio...rity, today announced the general availability of ...m Center (DCSC) to enable users to protect corpor...
(Date:11/9/2009)... New Health Care Reform Bill, The Affordabl...House Of Representatives Saturday Night, and Is Ex...a by the End of the Year with Absolute Confidence....st Certification Class Specifically for the Compli...f Americans , Hanover Par...
(Date:11/9/2009)... A new website providing support and inform...been launched at TheFaceofLungCancer.org. The site...ile distilling important information and advocatin... (PRWEB) November 9, 2009 -- With health c...and in recognition of November’s designation...
Breaking Medicine News(10 mins):Health News:Davis Bregman MD Now Offering House Calls in Manhattan 2Health News:Lumension Announces General Availability of its Data Protection Solution for Microsoft System Center and Joins Microsoft System Center Alliance 2Health News:Lumension Announces General Availability of its Data Protection Solution for Microsoft System Center and Joins Microsoft System Center Alliance 3Health News:Lumension Announces General Availability of its Data Protection Solution for Microsoft System Center and Joins Microsoft System Center Alliance 4Health News:The New Healthcare Reform Bill Passed by The Congress Prompted The New Claim Specialist Certification Class from ERISAclaim.com 2Health News:The New Healthcare Reform Bill Passed by The Congress Prompted The New Claim Specialist Certification Class from ERISAclaim.com 3Health News:The New Healthcare Reform Bill Passed by The Congress Prompted The New Claim Specialist Certification Class from ERISAclaim.com 4Health News:The New Healthcare Reform Bill Passed by The Congress Prompted The New Claim Specialist Certification Class from ERISAclaim.com 5Health News:The Face of Lung Cancer Support and Information Website Launches to Increase Awareness and Advocacy 2Health News:The Face of Lung Cancer Support and Information Website Launches to Increase Awareness and Advocacy 3
...ces may be causing the surface of the earth to sli...erican scientists, which has been published by the...Carlo Doglioni of Rome's La Sapienza University an... into vast plates that slowly shift, producing ear...
...tion from Singapore in search of 'Bigfoot', an ape...een postponed until 21 January 2006. //This has be...aysia. This has been revealed by the Singapore Par...of 20 members to solve it. Three of the creatures,...
...sian market vendor who came into close contact wit... H5N1 strain of the bird flu virus.// Health autho...onfirmed that the 22-year-old man carried the viru... toll in the country will rise to 15. The WHO ...
...released by China's Ministry of Health, the World ...V/AIDS cases prevailing in the country, //is raisi...y quoted, the New York Times reports. A repor...e number of full-blown cases at 75,000. The report...
...h Secretary of Britain is planning to introduce a ...s aimed at reducing long hours of waiting to avail...The new facility will allow the patients to see th... their appointment in big hospitals which does not...
...ficials in India have revealed that the country is...ountry has set itself a target of less than one le...ing the early 1980s, when the Multi Drug Therapy (...er 2005. // At least 11.27 million leprosy c...
Other Medicine News:
PCS®2 System
Elutra Cell Separation System
Plasma Extractor
Multipette
Medicine Products: